EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Diagnosis of Primary Aldosteronism without Discontinuation of Interfering Antihypertensive Medications

Zhichao Dong, Xiaoxiao Song, Minyue Jia, Jinliang Chen, Yuhao Zhang, Hanxiao Yu, Yongli Ji, Lizhen Shan, Tianyue Zhang, Chao Zheng, Jiaming Wen, Xiaohong Xu

Current Hypertension Reports · 2025

DOI: 10.1007/s11906-024-01319-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Hypertension Reports, 2025. Verfasst von Zhichao Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Hyperaldosteronism, Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF REVIEW: One of the challenges in the diagnosis and management of primary aldosteronism (PA), the most common type of secondary hypertension with curative potential, is the modification of antihypertensive medications. We seek to explore whether these medications can be continued during the diagnostic process of PA to minimize the duration and risks associated with medication adjustments. RECENT FINDINGS: We searched PubMed for eligible original literature between 1990 and 2024 using the following keywords: (screening) AND (primary aldosteronism); (confirmatory) AND (primary aldosteronism); (adrenal vein sampling) AND primary aldosteronism). Some recent studies support the feasibility of PA-related tests and even adrenal vein sampling (AVS) without the need to discontinue antihypertensive medications in certain cases. In this review, we propose a management approach that considers the specific effects of antihypertensive medications on the RAAS axis and the patient's disease phenotype. Based on this, we suggest a strategy that enables the diagnosis of PA in certain patients without discontinuing their antihypertensive medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismAntihypertensive AgentsHypertensionHumansAdrenal GlandsRenin-Angiotensin System

Stichwörter der Autor:innen

Adrenal vein samplingAldosteroneAldosterone to renin ratioPrimary aldosteronismRenin

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Urology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine, No.88, Jiefang Road, Shangcheng District, Hangzhou, 310000, China.
  • Department of Ultrasonography, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Center for Basic and Translational Research, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine, No.88, Jiefang Road, Shangcheng District, Hangzhou, 310000, China. chao_zheng@zju.edu.cn.
  • Department of Urology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. wenjiaming@zju.edu.cn.

Zitieren

APA

Dong, Z., Song, X., Jia, M., Chen, J., Zhang, Y., Yu, H., Ji, Y., Shan, L., Zhang, T., Zheng, C., Wen, J., & Xu, X. (2025). Diagnosis of Primary Aldosteronism without Discontinuation of Interfering Antihypertensive Medications. Current Hypertension Reports. https://doi.org/10.1007/s11906-024-01319-y

Vancouver

Dong Z, Song X, Jia M, Chen J, Zhang Y, Yu H, et al. Diagnosis of Primary Aldosteronism without Discontinuation of Interfering Antihypertensive Medications. Current Hypertension Reports. 2025. doi:10.1007/s11906-024-01319-y

BibTeX
@article{Dong2025,
  author = {Dong, Zhichao and Song, Xiaoxiao and Jia, Minyue and Chen, Jinliang and Zhang, Yuhao and Yu, Hanxiao and Ji, Yongli and Shan, Lizhen and Zhang, Tianyue and Zheng, Chao and Wen, Jiaming and Xu, Xiaohong},
  title = {Diagnosis of Primary Aldosteronism without Discontinuation of Interfering Antihypertensive Medications},
  journal = {Current Hypertension Reports},
  year = {2025},
  doi = {10.1007/s11906-024-01319-y}
}
Kostenlos starten →